Infection with Mansonella Perstans Nematodes in Buruli Ulcer Patients
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca Volvulus Excretory Secretory Products
pathogens Review The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca volvulus Excretory Secretory Products Luc Vanhamme 1,*, Jacob Souopgui 1 , Stephen Ghogomu 2 and Ferdinand Ngale Njume 1,2 1 Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Université Libre de Bruxelles, Rue des Professeurs Jeener et Brachet 12, 6041 Gosselies, Belgium; [email protected] (J.S.); [email protected] (F.N.N.) 2 Molecular and Cell Biology Laboratory, Biotechnology Unit, University of Buea, Buea P.O Box 63, Cameroon; [email protected] * Correspondence: [email protected] Received: 28 October 2020; Accepted: 18 November 2020; Published: 23 November 2020 Abstract: Nematodes constitute a very successful phylum, especially in terms of parasitism. Inside their mammalian hosts, parasitic nematodes mainly dwell in the digestive tract (geohelminths) or in the vascular system (filariae). One of their main characteristics is their long sojourn inside the body where they are accessible to the immune system. Several strategies are used by parasites in order to counteract the immune attacks. One of them is the expression of molecules interfering with the function of the immune system. Excretory-secretory products (ESPs) pertain to this category. This is, however, not their only biological function, as they seem also involved in other mechanisms such as pathogenicity or parasitic cycle (molting, for example). Wewill mainly focus on filariae ESPs with an emphasis on data available regarding Onchocerca volvulus, but we will also refer to a few relevant/illustrative examples related to other worm categories when necessary (geohelminth nematodes, trematodes or cestodes). -
Eisai Announces Results and Continued Support Of
No.17-18 April 19, 2017 Eisai Co., Ltd. EISAI ANNOUNCES RESULTS AND CONTINUED SUPPORT OF INITIATIVES FOR ELIMINATION OF LYMPHATIC FILARIASIS 5 YEAR ANNIVERSARY OF LONDON DECLARATION ON NEGLECTED TROPICAL DISEASES Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced the results of its initiatives for the elimination of lymphatic filariasis (LF), and its continued support of this cause in the future. This announcement was made at an event held in Geneva, Switzerland, on April 18, marking the 5th anniversary of the London Declaration on Neglected Tropical Diseases (NTDs), an international public-private partnership. Announced in January 2012, the London Declaration is the largest public-private partnership in the field of global health, and represents a coordinated effort by global pharmaceutical companies, the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the United States, United Kingdom and NTD-endemic country governments, as well as other partners, to eliminate 10 NTDs by the year 2020. Since the signing of the London Declaration, donations of medical treatments by pharmaceutical companies have increased by 70 percent, and these treatments contribute to the prevention and cure of disease in approximately 1 billion people every year. Under the London Declaration, Eisai signed an agreement with WHO to supply 2.2 billion high-quality diethylcarbamazine (DEC) tablets, which were running in short supply worldwide, at Price Zero (free of charge) by the year 2020. These DEC tablets are manufactured at Eisai’s Vizag Plant in India. As of the end of March 2017, 1 billion tablets have been supplied to 27 endemic countries. -
Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being
Research and Reviews on Healthcare: Open Access Journal DOI: 10.32474/RRHOAJ.2020.06.000226 ISSN: 2637-6679 Research Article Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being Firew Admasu Hailu1*, Geremew Tafesse1 and Tsion Admasu Hailu2 1Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia 2Addis Ababa Medical and Business College, Addis Ababa, Ethiopia *Corresponding author: Firew Admasu Hailu, Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia Received: November 05, 2020 Published: November 20, 2020 Abstract Introduction: This study mainly focus on the major pathologic manifestations of human gastrointestinal impacts of parasitic worms. Background: Helminthes and protozoan are human parasites that can infect gastrointestinal tract of humans beings and reside in intestinal wall. Protozoans are one celled microscopic, able to multiply in humans, contributes to their survival, permits serious infections, use one of the four main modes of transmission (direct, fecal-oral, vector-borne, and predator-prey) and also helminthes are necked multicellular organisms, referred as intestinal worms even though not all helminthes reside in intestines. However, in their adult form, helminthes cannot multiply in humans and able to survive in mammalian host for many years due to their ability to manipulate immune response. Objectives: The objectives of this study is to assess the main pathophysiology and gastrointestinal impacts of parasitic worms in human being. Methods: Both primary and secondary data were collected using direct observation, books and articles, and also analyzed quantitativelyResults and and conclusion: qualitatively Parasites following are standard organisms scientific living temporarily methods. in or on other organisms called host like human and other animals. -
Co-Infection with Onchocerca Volvulus and Loa Loa Microfilariae in Central Cameroon: Are These Two Species Interacting?
843 Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting? S. D. S. PION1,2*, P. CLARKE3, J. A. N. FILIPE2,J.KAMGNO1,J.GARDON1,4, M.-G. BASA´ N˜ EZ2 and M. BOUSSINESQ1,5 1 Laboratoire mixte IRD (Institut de Recherche pour le De´veloppement) – CPC (Centre Pasteur du Cameroun) d’Epide´miologie et de Sante´ publique, Centre Pasteur du Cameroun, BP 1274, Yaounde´, Cameroun 2 Department of Infectious Disease Epidemiology, St Mary’s campus, Norfolk Place, London W2 1PG, UK 3 Infectious Disease Epidemiology Unit London School of Hygiene and Tropical Medicine Keppel Street, London WC1E 7HT, UK 4 Institut de Recherche pour le De´veloppement, UR 24 Epide´miologie et Pre´vention, CP 9214 Obrajes, La Paz, Bolivia 5 Institut de Recherche pour le De´veloppement, De´partement Socie´te´s et Sante´, 213 rue La Fayette, 75480 Paris Cedex 10, France (Received 16 August 2005; revised 3 October; revised 9 December 2005; accepted 9 December 2005; first published online 10 February 2006) SUMMARY Ivermectin treatment may induce severe adverse reactions in some individuals heavily infected with Loa loa. This hampers the implementation of mass ivermectin treatment against onchocerciasis in areas where Onchocerca volvulus and L. loa are co-endemic. In order to identify factors, including co-infections, which may explain the presence of high L. loa micro- filaraemia in some individuals, we analysed data collected in 19 villages of central Cameroon. Two standardized skin snips and 30 ml of blood were obtained from each of 3190 participants and the microfilarial (mf) loads of both O. -
Hookworm-Related Cutaneous Larva Migrans
326 Hookworm-Related Cutaneous Larva Migrans Patrick Hochedez , MD , and Eric Caumes , MD Département des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, Paris, France DOI: 10.1111/j.1708-8305.2007.00148.x Downloaded from https://academic.oup.com/jtm/article/14/5/326/1808671 by guest on 27 September 2021 utaneous larva migrans (CLM) is the most fre- Risk factors for developing HrCLM have specifi - Cquent travel-associated skin disease of tropical cally been investigated in one outbreak in Canadian origin. 1,2 This dermatosis fi rst described as CLM by tourists: less frequent use of protective footwear Lee in 1874 was later attributed to the subcutane- while walking on the beach was signifi cantly associ- ous migration of Ancylostoma larvae by White and ated with a higher risk of developing the disease, Dove in 1929. 3,4 Since then, this skin disease has also with a risk ratio of 4. Moreover, affected patients been called creeping eruption, creeping verminous were somewhat younger than unaffected travelers dermatitis, sand worm eruption, or plumber ’ s itch, (36.9 vs 41.2 yr, p = 0.014). There was no correla- which adds to the confusion. It has been suggested tion between the reported amount of time spent on to name this disease hookworm-related cutaneous the beach and the risk of developing CLM. Consid- larva migrans (HrCLM).5 ering animals in the neighborhood, 90% of the Although frequent, this tropical dermatosis is travelers in that study reported seeing cats on the not suffi ciently well known by Western physicians, beach and around the hotel area, and only 1.5% and this can delay diagnosis and effective treatment. -
Genomics of Loa Loa, a Wolbachia-Free Filarial Parasite of Humans
ARTICLES OPEN Genomics of Loa loa, a Wolbachia-free filarial parasite of humans Christopher A Desjardins1, Gustavo C Cerqueira1, Jonathan M Goldberg1, Julie C Dunning Hotopp2, Brian J Haas1, Jeremy Zucker1, José M C Ribeiro3, Sakina Saif1, Joshua Z Levin1, Lin Fan1, Qiandong Zeng1, Carsten Russ1, Jennifer R Wortman1, Doran L Fink4,5, Bruce W Birren1 & Thomas B Nutman4 Loa loa, the African eyeworm, is a major filarial pathogen of humans. Unlike most filariae, L. loa does not contain the obligate intracellular Wolbachia endosymbiont. We describe the 91.4-Mb genome of L. loa and that of the related filarial parasite Wuchereria bancrofti and predict 14,907 L. loa genes on the basis of microfilarial RNA sequencing. By comparing these genomes to that of another filarial parasite, Brugia malayi, and to those of several other nematodes, we demonstrate synteny among filariae but not with nonparasitic nematodes. The L. loa genome encodes many immunologically relevant genes, as well as protein kinases targeted by drugs currently approved for use in humans. Despite lacking Wolbachia, L. loa shows no new metabolic synthesis or transport capabilities compared to other filariae. These results suggest that the role of Wolbachia in filarial biology is more subtle All rights reserved. than previously thought and reveal marked differences between parasitic and nonparasitic nematodes. Filarial nematodes dwell within the lymphatics and subcutaneous (but not the worm itself) have shown efficacy in treating humans tissues of up to 170 million people worldwide and are responsible with these infections4,5. Through genomic analysis, Wolbachia have for notable morbidity, disability and socioeconomic loss1. -
Chronic Symptomatic and Microfilaremic Loiasis in a Returned Traveller
CMAJ Practice Clinical images Chronic symptomatic and microfilaremic loiasis in a returned traveller Courtney Thompson BSc MD, Ajith Cy MBBS MD, Andrea K. Boggild MSc MD 24-year-old woman presented for eval- Competing interests: None uation of eosinophilia (4.3 [normal declared. 0.04–0.4] × 109/L), generalized pruritis This article has been peer A reviewed. and recurrent migratory swelling of the wrists. Her symptoms had begun six months after her The authors have obtained return from a three-week stay in rural Camer- patient consent. oon, and had been ongoing for three years. Affiliations:Department of Owing to the epidemiologic and clinical history Medicine (Thompson, Cy, Boggild), University of compatible with loiasis, a blood smear was sub- Toronto; Public Health mitted for microscopic examination, which con- Figure 1: Adult stage of the filarial nematode Loa loa Ontario Laboratories firmed the presence of Loa loa microfilariae migrating in the conjunctiva of the left eye of a (Boggild), Public Health (microfilaremia). 24-year-old woman who had travelled to Cameroon. Ontario; Tropical Disease Unit, Division of Infectious While waiting for treatment with medications Diseases (Boggild), available only through the Special Access Pro- tomatic disease is more common among short- University Health Network- gramme of Health Canada, the patient presented term travellers, the presence of microfilaremia is Toronto General Hospital, to the emergency department with the sensation more consistently seen in patients from endemic Toronto, Ont. of a foreign body in her left eye (Figure 1), and areas who often show no symptoms. Microfilare- Correspondence to: was found to have a nemotode migrating in the mia is not commonly seen in expatriates or trav- Andrea Boggild, andrea [email protected] conjunctiva. -
The Immunology of Filariasis*
Articles in the Update series Les articles de la rubrique give a concise, authoritative, Le point fournissent un and up-to-date survey of the bilan concis et fiable de la present position in the se- situation actuelle dans le a e lected fields, and, over a domaine considere. Des ex- ,,v period of years, will cover / perts couvriront ainsi suc- / many different aspects of cessivement de nombreux the biomedical sciences aspects des sciences bio- e nVlfo l l gZ / / and public health. Most of medicales et de la sante the articles will be writ- publique. La plupart de ces ten, by invitation, by ac- articles auront donc ee knowledged experts on the rediges sur demande par les subject. specialistes les plus autorises. Bulletin of the World Health Organization, 59 (1): 1-8 (1981) The immunology of filariasis* SCIENTIFIC WORKING GROUP ON FILARIASIS1 This report summarizes the available information on the immunology of filariasis, and discusses immunodiagnosis and the immunologicalfactors influencing the host-parasite relationship in lymphaticfilariasis and onchocerciasis. Severalareas that requirefurther research are identifed, particularly concerning the development of new serological techniques, and the fractionation of specific antigens. The problems associated with vaccine development are considered and the importance of finding better animal modelsfor research is stressed. Lymphatic filariasis and onchocerciasis are recognized as important public health problems in many tropical and subtropical areas. However, until recently, little was known about the natural history of filariasis or the immune mechanisms involved. This report summarizes current knowledge on various aspects of the immunology of the disease and outlines areas for future research. -
1 Summary of the Thirteenth Meeting of the ITFDE (II) October 29, 2008
Summary of the Thirteenth Meeting of the ITFDE (II) October 29, 2008 The Thirteenth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 8:30am to 4:00 pm on October 29, 2008. Topics discussed at this meeting were the status of the global campaigns to eliminate lymphatic filariasis (LF) and to eradicate dracunculiasis (Guinea worm disease), an update on efforts to eliminate malaria and LF from the Caribbean island of Hispaniola (Dominican Republic and Haiti), and a report on the First Program Review for Buruli ulcer programs. The Task Force members are Dr. Olusoji Adeyi, The World Bank; Sir George Alleyne, Johns Hopkins University; Dr. Julie Gerberding, Centers for Disease Control and Prevention (CDC); Dr. Donald Hopkins, The Carter Center (Chair); Dr. Adetokunbo Lucas, Harvard University; Professor David Molyneux, Liverpool School of Tropical Medicine (Rtd.); Dr. Mark Rosenberg, Task Force for Child Survival and Development; Dr. Peter Salama, UNICEF; Dr. Lorenzo Savioli, World Health Organization (WHO); Dr. Harrison Spencer, Association of Schools of Public Health; Dr. Dyann Wirth, Harvard School of Public Health, and Dr. Yoichi Yamagata, Japan International Cooperation Agency (JICA). Four of the Task Force members (Hopkins, Adeyi, Lucas, Rosenberg) attended this meeting, and three others were represented by alternates (Dr. Stephen Blount for Gerberding, Dr. Mark Young for Dr. Salama, Dr. Dirk Engels for Savioli). Presenters at this meeting were Dr. Eric Ottesen of the Task Force for Child Survival and Development, Dr. Patrick Lammie of the CDC, Dr. Ernesto Ruiz-Tiben of The Carter Center, Dr. David Joa Espinal of the National Center for Tropical Disease Control (CENCET) in the Dominican Republic, and Dr. -
2. Studies on the Multiplication of Chkunya Virus (CHV), and on Physical and Chemical Structure of Its Virion
71 PAPER IN SCIENTIFIC SESSION GROUP A: Immunology and Viral Diseases 1. Principles and Applications of Fluorescent Antibody Technique in Tropical Medicine Akira Kawamura Department of Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan 2. Studies on the Multiplication of Chkunya Virus (CHV), and on Physical and Chemical Structure of its Virion Noboru Higashi,Yasuko Nagatomo, Akira Tamura and Toshio Ametani Virus Institute, Kyoto University, Kyoto, Japan 3. Electronmicroscopic Studies on the Multiplications of Japanese Encephalitis Viurs Noboru Higashi*, Toshiko Ametani*, Yasuko Nagatomo*, Eiichi Fujiwara* and Takashi Tsuruhara** *Virus Institute, Kyoto Uniuersity, Kyoto, Japan and **NIH of Japan , Tokyo, Japan 4. Electromicroscopic Studies on the Multiplication of Dengue Virus Noboru Higashi*, Masao Tokuda*, Toshio Ametani*, Mya-Tu, My My Khin** and Toe Myint** *Virus Institute, Kyoto University, Kyoto, Japan and **Viral Section , Burma Medical Institute, Buruma 72 5. A Plaque Assay of Dengue and Other Arboviruses in Monolayer Cultures of BHK-21 Cells Hideo Aoki Department of Microbiology, School of Medicine Kobe University, Kobe, Japan A cell line of baby hamster kidney (BHK-21, clone 13) was found suitable for titration and multiplication of many kinds of arboviruses, including all types of dengue and related viruses. For instance, dengue (type 1, Hawaiian, Mochizuki ; type 2, New Guinea B ; type 3, H-87 ; type 4, H-241 ; type 5 ? Th-36 ; type 6 ? Th-Sman), JBE Nakayama, JaGar # 01, Gl) and Chikungunya (African) viruses are capable of producing clear plaques in monolayer cultures of the cells under a methyl cellulose overlay medium. By means of this plaque assay system, titration and neutralization of these arboviruses are possible. -
Filarial Worms
Filarial worms Blood & tissues Nematodes 1 Blood & tissues filarial worms • Wuchereria bancrofti • Brugia malayi & timori • Loa loa • Onchocerca volvulus • Mansonella spp • Dirofilaria immitis 2 General life cycle of filariae From Manson’s Tropical Diseases, 22 nd edition 3 Wuchereria bancrofti Life cycle 4 Lymphatic filariasis Clinical manifestations 1. Acute adenolymphangitis (ADLA) 2. Hydrocoele 3. Lymphoedema 4. Elephantiasis 5. Chyluria 6. Tropical pulmonary eosinophilia (TPE) 5 Figure 84.10 Sequence of development of the two types of acute filarial syndromes, acute dermatolymphangioadenitis (ADLA) and acute filarial lymphangitis (AFL), and their possible relationship to chronic filarial disease. From Manson’s tropical Diseases, 22 nd edition 6 Bancroftian filariasis Pathology 7 Lymphatic filariasis Parasitological Diagnosis • Usually diagnosis of microfilariae from blood but often negative (amicrofilaraemia does not exclude the disease!) • No relationship between microfilarial density and severity of the disease • Obtain a specimen at peak (9pm-3am for W.b) • Counting chamber technique: 100 ml blood + 0.9 ml of 3% acetic acid microscope. Species identification is difficult! 8 Lymphatic filariasis Parasitological Diagnosis • Staining (Giemsa, haematoxylin) . Observe differences in size, shape, nuclei location, etc. • Membrane filtration technique on venous blood (Nucleopore) and staining of filters (sensitive but costly) • Knott concentration technique with saponin (highly sensitive) may be used 9 The microfilaria of Wuchereria bancrofti are sheathed and measure 240-300 µm in stained blood smears and 275-320 µm in 2% formalin. They have a gently curved body, and a tail that becomes thinner to a point. The nuclear column (the cells that constitute the body of the microfilaria) is loosely packed; the cells can be visualized individually and do not extend to the tip of the tail. -
Historic Accounts of Mansonella Parasitaemias in the South Pacific and Their Relevance to Lymphatic Filariasis Elimination Efforts Today
Asian Pacific Journal of Tropical Medicine 2016; 9(3): 205–210 205 HOSTED BY Contents lists available at ScienceDirect Asian Pacific Journal of Tropical Medicine journal homepage: http://ees.elsevier.com/apjtm Review http://dx.doi.org/10.1016/j.apjtm.2016.01.040 Historic accounts of Mansonella parasitaemias in the South Pacific and their relevance to lymphatic filariasis elimination efforts today J. Lee Crainey*,Tullio´ Romão Ribeiro da Silva, Sergio Luiz Bessa Luz Ecologia de Doenças Transmissíveis na Amazonia,ˆ Instituto Leonidasˆ e Maria Deane-Fiocruz Amazoniaˆ Rua Terezina, 476. Adrian´opolis, CEP: 69.057-070, Manaus, Amazonas, Brazil ARTICLE INFO ABSTRACT Article history: There are two species of filarial parasites with sheathless microfilariae known to Received 15 Dec 2015 commonly cause parasitaemias in humans: Mansonella perstans and Mansonella ozzardi. Received in revised form 20 Dec In most contemporary accounts of the distribution of these parasites, neither is usually 2015 considered to occur anywhere in the Eastern Hemisphere. However, Sir Patrick Manson, Accepted 30 Dec 2015 who first described both parasite species, recorded the existence of sheathless sharp-tailed Available online 11 Jan 2016 Mansonella ozzardi-like parasites occurring in the blood of natives from New Guinea in each and every version of his manual for tropical disease that he wrote before his death in 1922. Manson's reports were based on his own identifications and were made from at Keywords: least two independent blood sample collections that were taken from the island. Pacific Mansonella ozzardi region Mansonella perstans parasitaemias were also later (in 1923) reported to occur in Mansonella perstans New Guinea and once before this (in 1905) in Fiji.